On May 2nd, Hanyu Pharmaceutical said on the interactive platform today that as of today, the company's liraglutide preparations and a variety of GLP-1 API contracted orders totaled nearly 600 million yuan, and some orders have been shipped one after another; The preparation production base has obtained European Union GMP certification and US cGMP certification, and the API production base has passed Australian TGA-GMP certification and US cGMP certification.